ESTC heads into the last week of September with a notable tension: insider selling at the executive level has been heavy, yet the analyst community is raising targets and the stock is holding up far better than most of its software peers.
The insider angle is impossible to ignore. Shay Banon, Elastic's co-founder and Chief Technology Officer, sold roughly 240,000 shares across September 9 and September 14 — a combined value of around $19 million at prices between $84.50 and $88. None of these sales were flagged as being executed under a pre-arranged 10b5-1 plan, meaning they were discretionary trades, not scheduled liquidations. The CFO and Chief Revenue Officer each sold on September 9 as well, adding around $1.6 million more to the insider exit tally. Net insider activity over the past 90 days totals nearly -$98.4 million across -1.1 million shares. Banon's institutional filing tells a similar story: his last-disclosed stake, as of September 14, has dropped to around 5.1% of shares outstanding — down from the 6.1% reported last November — and the institutional register shows the position fell by roughly 982,000 shares in the most recent update. As always with 13D/G filings, stakes are as last disclosed around the 5% threshold, and a holder who drops below that level is not required to file again.
The Street, by contrast, is leaning bullish. After Elastic's August 27 earnings print — which sent the stock up 26% in a single session — a wave of analysts lifted targets on August 28. Barclays moved to $118 from $94, Citigroup raised to $128 from $104, and Piper Sandler jumped to $130 from $85, all while maintaining positive ratings. More recently, Wedbush initiated with Outperform and a $125 target on September 11. The consensus mean price target now sits at $110.69, implying roughly 24% upside from the current $89.22 close. The bull case centres on enterprise consolidation of monitoring and security tools, a growing AI-assisted observability product set, and a subscriber base that has continued to expand. Bears acknowledge the earnings strength but flag aggressive expansion into competitive security markets as a potential margin drag, and note that heavy reliance on large enterprise accounts creates concentration risk. The analyst recommendation differential factor scores in the 94th percentile — one of the strongest readings in the dataset — suggesting the Street's positive tilt is unusually wide.
The post-earnings short covering tells its own story. Short interest nearly halved between early September and mid-September, falling from around 6.2 million shares to roughly 3.9 million — a drop of more than 34% over the past month. The current level, 3.7% of free float, is modest. The borrow market reflects no stress whatsoever: availability is extraordinarily loose at nearly 5,000% — meaning there are roughly 50 shares available to borrow for every one currently lent out — and cost to borrow at 0.52% is barely above the risk-free rate, even after a 37% rise on the week. Options traders are even less concerned about downside than usual. The put/call ratio at 0.28 sits below its 20-day average of 0.31, and roughly 0.8 standard deviations below that mean, placing it toward the more optimistic end of the past year's range. That 52-week high on the PCR was 0.66 — the current reading is less than half that level.
The stock's resilience stands out when measured against peers. WDAY fell 1.9% on the day and 1.3% on the week. NOW dropped 3.5% on the week. PATH gave back nearly 6.9%. CRM lost 8.8% over the same period. ESTC gained 4.8% on the week — a meaningful positive divergence after the post-earnings re-rating brought new institutional buyers into the register. BlackRock added 972,000 shares in its most recently reported period through August 31, and D.E. Shaw built a position that grew by 1.3 million shares through June 30.
Pictet Asset Management is also worth watching: it filed a Schedule 13D/A — an activist-type filing — as recently as September 2, disclosing that its stake has edged down to 4.9% from 5.2%. A filing under Schedule 13D carries stronger disclosure requirements than a passive 13G, and Pictet's continued presence on the register on an activist form type is worth monitoring, though the firm has not publicly stated any confrontational intent. Positions are as last disclosed and Pictet, now below the 5% threshold, is not required to file further updates.
The next scheduled earnings event falls on November 19. Between now and then, the central question is whether the insider selling — particularly the discretionary, unplanned nature of Banon's cluster of trades — is a signal of comfort with the current valuation after a 26% post-earnings gap, or something more considered. The PE multiple has expanded to 23.5x and the EV/EBITDA has compressed to 18.6x over the past 30 days as earnings power improves, but the value factor score remains thin at the 8th percentile on forward EPS growth year-over-year. What to watch: whether additional insider filings appear ahead of the November print, and whether the analyst target upgrades translate into sustained institutional accumulation or merely a post-earnings pop that fades as the stock approaches the upper end of the target range.
See the live data behind this article on ORTEX.
Open ESTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
